ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,688 Cr | ₹1,554 Cr | ₹1,225 Cr | ₹1,111 Cr | ₹1,237 Cr |
What is the latest Total Liabilities ratio of ORCHID PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,688 Cr |
| Mar2024 | ₹1,554 Cr |
| Mar2023 | ₹1,225 Cr |
| Mar2022 | ₹1,111 Cr |
| Mar2021 | ₹1,237 Cr |
How is Total Liabilities of ORCHID PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,688 Cr | 8.62 | |
| Mar2024 | ₹1,554 Cr | 26.83 | |
| Mar2023 | ₹1,225 Cr | 10.32 | |
| Mar2022 | ₹1,111 Cr | -10.24 | |
| Mar2021 | ₹1,237 Cr | - | |
Compare Total Liabilities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹6,449.1 Cr | 7.2% | 6.8% | 29.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.4% | 0.9% | 19.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | -1.2% | 21.1% | 29.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.3% | 0.3% | 34.8% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.7% | 1.5% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | -0.3% | -7.1% | -3.9% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 7.2% |
6.8% |
29.3% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses